Sort
16,300 grants matching “fatty liver disease”
TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITIS
$418,815Brian N Finck · Washington University · R01 · FY2019 · DK
TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITIS
$418,815Brian N Finck · Washington University · R01 · FY2018 · DK
Role of SAMe in the Progression of Nonalcoholic Fatty Liver Disease
$418,808Shelly Chi-Loo Lu · Cedars-Sinai Medical Center · R01 · FY2022 · DK
Reactive Species in Vascular Disease: Mechanisms of Injury
$418,750Harry Ischiropoulos · Children'S Hosp Of Philadelphia · R01 · FY2011 · HL
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1
$418,750Gerald I Shulman · Yale University · R01 · FY2020 · DK
Impact of dysbiosis on the development of age-related inflammation
$418,750Vishwa Deep Dixit · Yale University · R01 · FY2021 · AG
Regulation of white fat browning by a novel, brown fat-secreted adipokine
$418,750Yong-Xu Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2018 · DK
A novel adipokine suppresses leptin signaling and promotes obesity
$418,750Yong-Xu Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · DK
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1
$418,750Gerald I Shulman · Yale University · R01 · FY2018 · DK
Impact of dysbiosis on the development of age-related inflammation
$418,750Vishwa Deep Dixit · Yale University · R01 · FY2023 · AG
A novel adipokine suppresses leptin signaling and promotes obesity
$418,750Yong-Xu Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · DK
Regulation of white fat browning by a novel, brown fat-secreted adipokine
$418,750Yong-Xu Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · DK
A novel adipokine suppresses leptin signaling and promotes obesity
$418,750Yong-Xu Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · DK
Mechanistic Target of Rapamycin Pathways in Metabolism and Energy Expenditure
$418,750David A Guertin · Univ Of Massachusetts Med Sch Worcester · R56 · FY2018 · DK
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1
$418,750Gerald I Shulman · Yale University · R01 · FY2021 · DK
A novel adipokine suppresses leptin signaling and promotes obesity
$418,750Yong-Xu Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2020 · DK
Impact of dysbiosis on the development of age-related inflammation
$418,750Vishwa Deep Dixit · Yale University · R01 · FY2022 · AG
Regulation of white fat browning by a novel, brown fat-secreted adipokine
$418,750Yong-Xu Wang · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · DK
Reactive Species in Vascular Disease: Mechanisms of Injury
$418,750Harry Ischiropoulos · Children'S Hosp Of Philadelphia · R01 · FY2012 · HL
Cellular interactions between TGF-beta pathway members and epigenetic regulators in liver and gastrointestinal cancers
$418,750Lopa Mishra · Feinstein Institute For Medical Research · R01 · FY2025 · CA
Glucagon Regulation of Hepatic Mitochondrial Activity and Glucose Metabolism by InsP3R-1
$418,750Gerald I Shulman · Yale University · R01 · FY2019 · DK
Impact of dysbiosis on the development of age-related inflammation
$418,750Vishwa Deep Dixit · Yale University · R01 · FY2020 · AG
Impact of dysbiosis on the development of age-related inflammation
$418,750Vishwa Deep Dixit · Yale University · R01 · FY2024 · AG
Pathobiology of Liver Injury
$418,693Harmeet Malhi · Mayo Clinic Rochester · R01 · FY2022 · DK
The Role of G Proteins in Insulin Action
$418,621Alan R. Saltiel · University Of California, San Diego · R01 · FY2015 · DK